These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles. Merle NS; Grunenwald A; Rajaratnam H; Gnemmi V; Frimat M; Figueres ML; Knockaert S; Bouzekri S; Charue D; Noe R; Robe-Rybkine T; Le-Hoang M; Brinkman N; Gentinetta T; Edler M; Petrillo S; Tolosano E; Miescher S; Le Jeune S; Houillier P; Chauvet S; Rabant M; Dimitrov JD; Fremeaux-Bacchi V; Blanc-Brude OP; Roumenina LT JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925688 [TBL] [Abstract][Full Text] [Related]
14. Assessment of total and unbound cell-free heme in plasma of patients with sickle cell disease. Vissa M; Larkin SK; Vichinsky EP; Kuypers FA; Soupene E Exp Biol Med (Maywood); 2023 May; 248(10):897-907. PubMed ID: 36941786 [TBL] [Abstract][Full Text] [Related]
15. Different target specificities of haptoglobin and hemopexin define a sequential protection system against vascular hemoglobin toxicity. Deuel JW; Vallelian F; Schaer CA; Puglia M; Buehler PW; Schaer DJ Free Radic Biol Med; 2015 Dec; 89():931-43. PubMed ID: 26475040 [TBL] [Abstract][Full Text] [Related]
16. Free heme exacerbates colonic injury induced by anti-cancer therapy. Seika P; Janikova M; Asokan S; Janovicova L; Csizmadia E; O'Connell M; Robson SC; Glickman J; Wegiel B Front Immunol; 2023; 14():1184105. PubMed ID: 37342339 [TBL] [Abstract][Full Text] [Related]
17. Safety and feasibility of the gene transfer of hemopexin for conditions with increased free heme. de Lima F; Hounkpe BW; de Moraes CRP; Borba-Junior IT; Costa FF; De Paula EV Exp Biol Med (Maywood); 2023 Jul; 248(13):1103-1111. PubMed ID: 37452705 [TBL] [Abstract][Full Text] [Related]
18. Impact of intravascular hemolysis in malaria on liver dysfunction: involvement of hepatic free heme overload, NF-κB activation, and neutrophil infiltration. Dey S; Bindu S; Goyal M; Pal C; Alam A; Iqbal MS; Kumar R; Sarkar S; Bandyopadhyay U J Biol Chem; 2012 Aug; 287(32):26630-46. PubMed ID: 22696214 [TBL] [Abstract][Full Text] [Related]
19. Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease. Vinchi F; Costa da Silva M; Ingoglia G; Petrillo S; Brinkman N; Zuercher A; Cerwenka A; Tolosano E; Muckenthaler MU Blood; 2016 Jan; 127(4):473-86. PubMed ID: 26675351 [TBL] [Abstract][Full Text] [Related]
20. P-selectin drives complement attack on endothelium during intravascular hemolysis in TLR-4/heme-dependent manner. Merle NS; Paule R; Leon J; Daugan M; Robe-Rybkine T; Poillerat V; Torset C; Frémeaux-Bacchi V; Dimitrov JD; Roumenina LT Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6280-6285. PubMed ID: 30850533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]